BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31861093)

  • 1. A Hypothesis and Evidence That Mercury May be an Etiological Factor in Alzheimer's Disease.
    Siblerud R; Mutter J; Moore E; Naumann J; Walach H
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31861093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Potential Role of Mercury in Alzheimer's Disease.
    Bjørklund G; Tinkov AA; Dadar M; Rahman MM; Chirumbolo S; Skalny AV; Skalnaya MG; Haley BE; Ajsuvakova OP; Aaseth J
    J Mol Neurosci; 2019 Apr; 67(4):511-533. PubMed ID: 30877448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator.
    Mutter J; Naumann J; Sadaghiani C; Schneider R; Walach H
    Neuro Endocrinol Lett; 2004 Oct; 25(5):331-9. PubMed ID: 15580166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mercury and Alzheimer's disease].
    Mutter J; Naumann J; Schneider R; Walach H
    Fortschr Neurol Psychiatr; 2007 Sep; 75(9):528-38. PubMed ID: 17628833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation between mercury and Alzheimer's disease?].
    Schuurs AH; de Wolff FA
    Ned Tijdschr Tandheelkd; 1997 Jun; 104(6):219-22. PubMed ID: 11923917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Detection of Autism (ASD) by a Non-invasive Quick Measurement of Markedly Reduced Acetylcholine & DHEA and Increased β-Amyloid (1-42), Asbestos (Chrysotile), Titanium Dioxide, Al, Hg & often Coexisting Virus Infections (CMV, HPV 16 and 18), Bacterial Infections etc. in the Brain and Corresponding Safe Individualized Effective Treatment.
    Omura Y; Lu D; Jones MK; Nihrane A; Duvvi H; Shimotsuura Y; Ohki M
    Acupunct Electrother Res; 2015; 40(3):157-87. PubMed ID: 26829843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Review Regarding Mercury Poisoning and Its Complex Involvement in Alzheimer's Disease.
    Paduraru E; Iacob D; Rarinca V; Rusu A; Jijie R; Ilie OD; Ciobica A; Nicoara M; Doroftei B
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can mercury cause Alzheimer's disease?].
    Bjørklund G
    Tidsskr Nor Laegeforen; 1991 Aug; 111(19):2462. PubMed ID: 1926094
    [No Abstract]   [Full Text] [Related]  

  • 9. Mercury induced Alzheimer's disease: accelerating incidence?
    Ely JT
    Bull Environ Contam Toxicol; 2001 Dec; 67(6):800-6. PubMed ID: 11692193
    [No Abstract]   [Full Text] [Related]  

  • 10. Mercury and Alzheimer's disease: a look at the links and evidence.
    Azar J; Yousef MH; El-Fawal HAN; Abdelnaser A
    Metab Brain Dis; 2021 Mar; 36(3):361-374. PubMed ID: 33411216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amalgam risk assessment with coverage of references up to 2005].
    Mutter J; Naumann J; Walach H; Daschner F
    Gesundheitswesen; 2005 Mar; 67(3):204-16. PubMed ID: 15789284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that mercury from silver dental fillings may be an etiological factor in smoking.
    Siblerud RL; Kienholz E; Motl J
    Toxicol Lett; 1993 Jun; 68(3):307-10. PubMed ID: 8516784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents.
    Domingo JL
    J Alzheimers Dis; 2006 Nov; 10(2-3):331-41. PubMed ID: 17119296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.
    Lee J; Chan SL; Mattson MP
    Neuromolecular Med; 2002; 2(1):29-45. PubMed ID: 12230303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity.
    Godfrey ME; Wojcik DP; Krone CA
    J Alzheimers Dis; 2003 Jun; 5(3):189-95. PubMed ID: 12897404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches.
    Gholami A
    Neurosci Lett; 2023 Nov; 817():137532. PubMed ID: 37866702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.